Movatterモバイル変換

[0]ホーム
URL:

TW200505834A - Sulfamide derivative and the pharmaceutical composition thereof - Google Patents

Sulfamide derivative and the pharmaceutical composition thereof

Info

Publication number
TW200505834A
TW200505834ATW093107069ATW93107069ATW200505834ATW 200505834 ATW200505834 ATW 200505834ATW 093107069 ATW093107069 ATW 093107069ATW 93107069 ATW93107069 ATW 93107069ATW 200505834 ATW200505834 ATW 200505834A
Authority
TW
Taiwan
Prior art keywords
fomula
pharmaceutical composition
sulfamide derivative
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
TW093107069A
Other languages
Chinese (zh)
Inventor
Tomoyuki Shibata
Masaki Kiga
Hayato Iwadare
Naomi Shimazaki
Tomoki Echigo
Kosaku Fujiwara
Fumie Tanzawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo CofiledCriticalSankyo Co
Publication of TW200505834ApublicationCriticalpatent/TW200505834A/en

Links

Classifications

Landscapes

Abstract

The present invention provides a sulfamide derivative of the following fomula(I) and the pharmaceutically acceptable salts, and provides a pharmaceutical composition, which is administrated separatly in same time or with interval sulfamide derivative of the following fomula(I) and the pharmaceutically acceptable salts, and a compound of the fomula(IV) and the pharmaceutically acceptable salts etc. , (in fomula(I), R1~R8 is a hydrogen atom or a halogen atom etc., R9 or R10 is a hydrogen atom, an optionally substituted alkyl group etc.), and in fomula(IV), X is a benzoimidazolyl group, Y1 is an oxygen atom etc. Z is a 2,4-dioxothiazoridin-5-yl group etc., R is a hydrogen atom, C1-6 alkyl group etc., m is an integer of 1~5).
TW093107069A2003-03-182004-03-17Sulfamide derivative and the pharmaceutical composition thereofTW200505834A (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
JP20030736152003-03-18
JP20031125722003-04-17
JP20033792822003-11-10

Publications (1)

Publication NumberPublication Date
TW200505834Atrue TW200505834A (en)2005-02-16

Family

ID=33033079

Family Applications (1)

Application NumberTitlePriority DateFiling Date
TW093107069ATW200505834A (en)2003-03-182004-03-17Sulfamide derivative and the pharmaceutical composition thereof

Country Status (2)

CountryLink
TW (1)TW200505834A (en)
WO (1)WO2004083167A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
TW200630337A (en)2004-10-142006-09-01Euro Celtique SaPiperidinyl compounds and the use thereof
PL1650186T3 (en)*2004-10-222008-11-28Bioprojet Soc CivNovel dicarboxylic acid derivatives
GB0513702D0 (en)2005-07-042005-08-10Sterix LtdCompound
ES2481402T3 (en)2005-07-212014-07-30Ardea Biosciences, Inc. MEK N- (arylamino) sulfonamide inhibitors
US8101799B2 (en)2005-07-212012-01-24Ardea BiosciencesDerivatives of N-(arylamino) sulfonamides as inhibitors of MEK
SI1912636T1 (en)*2005-07-212014-08-29Ardea Biosciences, Inc.N-(arylamino)-sulfonamide inhibitors of mek
CN109053523B (en)2005-10-072022-03-25埃克塞利希斯股份有限公司Azetidines as MEK inhibitors for the treatment of proliferative diseases
CA2642665C (en)2006-02-092013-01-08Daiichi Sankyo Company, LimitedAnti-cancer pharmaceutical composition
US8247442B2 (en)2006-03-292012-08-21Purdue Pharma L.P.Benzenesulfonamide compounds and their use
WO2007121269A2 (en)*2006-04-112007-10-25Ardea Biosciences, Inc.N-aryl-n'alkyl sulfamides as mek inhibitors
US8937181B2 (en)2006-04-132015-01-20Purdue Pharma L.P.Benzenesulfonamide compounds and the use thereof
WO2007118853A1 (en)2006-04-132007-10-25Euro-Celtique S.A.Benzenesulfonamide compounds and their use as blockers of calcium channels
JP5311673B2 (en)2006-12-142013-10-09エグゼリクシス， インコーポレイテッド Method of using MEK inhibitor
ES2547303T3 (en)*2007-01-192015-10-05Ardea Biosciences, Inc. MEK inhibitors
TW201336497A (en)2007-02-082013-09-16Daiichi Sankyo Co Ltd Crystal form of thiazolidinedione compound and preparation method thereof
WO2008124118A1 (en)2007-04-092008-10-16Purdue Pharma L.P.Benzenesulfonyl compounds and the use therof
US8563732B2 (en)2007-05-312013-10-22Shionogi & Co., Ltd.Oxyimino compounds and the use thereof
US8765736B2 (en)2007-09-282014-07-01Purdue Pharma L.P.Benzenesulfonamide compounds and the use thereof
US8518934B2 (en)2008-06-112013-08-27Shonogi & Co., Ltd.Oxycarbamoyl compounds and the use thereof
TW201008936A (en)2008-07-312010-03-01Daiichi Sankyo Co LtdCrystalline forms of thiazolidinedione compound and its manufacturing method
WO2010013768A1 (en)2008-07-312010-02-04第一三共株式会社Crystal of thiazolidinedione compound, and process for production thereof
ES2399384T3 (en)2008-11-102013-04-01Bayer Schering Pharma Ag Sulfonamido substituted phenoxybenzamides
EP2491014A1 (en)2009-10-212012-08-29Bayer Pharma AktiengesellschaftSubstituted halophenoxybenzamide derivatives
EP2491016A1 (en)2009-10-212012-08-29Bayer Pharma AktiengesellschaftSubstituted benzosulphonamides
EP2491015A1 (en)2009-10-212012-08-29Bayer Pharma AktiengesellschaftSubstituted benzosulphonamides
JP2013542214A (en)2010-10-292013-11-21バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Substituted phenoxypyridines
HK1206611A1 (en)2012-05-312016-01-15Bayer Pharma AktiengesellschaftBiomarkers for determining effective response of treatments of hepatocellular carcinoma (hcc) patients
PE20191818A1 (en)2012-10-122019-12-27Exelixis Inc PROCESS FOR THE PREPARATION OF 1 - ({3,4-DIFLUORO-2 - [(2-FLUORO-4-IODOPHENYL) AMINO] PHENYL} CARBONYL) -3 - [(2S) -PIPERIDIN-2-IL] AZETIDIN-3OL
US10139415B2 (en)*2013-02-272018-11-27Daiichi Sankyo Company, LimitedMethod for predicting responsiveness to compound inhibiting MAPK signal transduction pathway
WO2018009638A1 (en)2016-07-062018-01-11The Regents Of The University Of MichiganMULTIFUNCTIONAL INHIBITORS OF MEK/PI3K AND mTOR/MEK/PI3K BIOLOGICAL PATHWAYS AND THERAPEUTIC METHODS USING THE SAME

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5567831A (en)*1995-08-161996-10-22Duguesne University Of The Holy GhostNon-steroidal sulfatase inhibitor compounds and their method of use
JP4320089B2 (en)*1999-07-062009-08-26あすか製薬株式会社 Phenylsulfamate derivatives
JP2002020362A (en)*2000-07-062002-01-23Nippon Oruganon KkNew biphenyl derivative

Also Published As

Publication numberPublication date
WO2004083167A1 (en)2004-09-30

Similar Documents

PublicationPublication DateTitle
TW200505834A (en)Sulfamide derivative and the pharmaceutical composition thereof
NZ536734A (en)Spiroindolinepiperidine derivatives
HUP0303756A2 (en)1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands and process for their preparation and pharmaceutical compositions containing them
AP1614A (en)New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
IL150650A0 (en)Piperidine derivatives and pharmaceutical compositions containing the same
ATE388958T1 (en) 4'-C-SUBSTITUTED 2-HALOADENOSINE DERIVATIVES
JO2354B1 (en)Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
TW200724136A (en)Pharmaceutical compositions comprising PPAR modulator
RS20050432A (en)Novel aromatic fluoroglycoside derivatives,pharmaceutical products containing said compounds and the use thereof
NO20051389L (en) Stabilized pharmaceutical composition containing basic aids
MX2009006334A (en)Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives.
TW200745034A (en)New compounds
WO2004000817A3 (en)Benzimidazole compounds and their use as estrogen agonists/antagonists
WO2001014330A3 (en)Phenylpiperazines as serotonin reuptake inhibitors
TW200744589A (en)Pharmaceutical composition
NO20062491L (en) Benzoxazine derivatives and their use
NO20045486L (en) New compounds and their use
YU56402A (en)8,8a-dihydro-indeno/1,2-d/thiazole derivatives with sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as medicament
JO2413B1 (en)Benzoxazine Derivatives And Uses Thereof
MXPA05013631A (en)Heterocyclic methyl sulfone derivative.
TW200606152A (en)Piperidine compound and process for preparing the same
NO20052074L (en) Substituted benzoxazinones and uses thereof.
MY140749A (en)Novel piperidine compound
NO20054135L (en) Kipolinone / benzoxazine derivatives and uses thereof
MX2010010471A (en)Novel tetrahydroisoquinoline derivative.
[8]ページ先頭
©2009-2025 Movatter.jp